{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:23:10Z","timestamp":1698664990872},"reference-count":18,"publisher":"Wiley","issue":"s1","license":[{"start":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T00:00:00Z","timestamp":1169078400000},"content-version":"vor","delay-in-days":17,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p> <jats:italic>\n            <jats:bold>Introduction:<\/jats:bold> Dedicated pacing modes, such as AAIsafeR, prevent ventricular (V) pacing in selected patients. We report our experience in consecutive unselected patients<\/jats:italic>.<\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Methods:<\/jats:bold> All data collected in recipients of Symphony DR 2550 pacemakers (ELA Medical, Montrouge, France) were retrospectively analyzed. At each visit, the percentage of V and atrial (A) pacing and the number of endless\u2010loop tachycardia (ELT) episodes detected by the device were retrieved. Data were pooled according to pacing mode and compared with non\u2010paired Student's t\u2010test.<\/jats:italic> <\/jats:p><jats:p> <jats:italic>Between April 2004 and July 2005, our center recruited 147 patients (mean age<\/jats:italic>=<jats:italic>80 \u00b1 9 years, 54% men) treated for AV block (n<\/jats:italic>=<jats:italic>58), sinus node dysfunction (n<\/jats:italic>=<jats:italic>48) or other indications (n<\/jats:italic>=<jats:italic>41). Mean age at implant was 80 \u00b1 9 years, and 54% were men. AAIsafeR(R) was programmed in 96 patients, DDD(R) in 43, DDI in 7, and DDD\/AMC in 1 patient. In DDD mode, the mean resting AV delay was set at 150 \u00b1 17 ms. Patients were seen 1 month after implantation of the pacing system to verify its proper function, and every 6 months thereafter. At each follow\u2010up, the percentage of ventricular and atrial pacing, and the number of ELT detected by the device, were recorded.<\/jats:italic><\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Results:<\/jats:bold> The mean follow\u2010up was 7 \u00b1 6 months (range 1\u201321). No device was reprogrammed from AAIsafeR(R) to DDDI(R) because of permanent AF. Only 6 devices (6.25%) were automatically reprogrammed from AAIsafeR(R) to DDD(R) during follow\u2010up due to permanent AV block. An empirical choice of AAIsafeR pacing mode at the time of implantation was effective in 94% of patients, allowing a significant decrease in the percentage of V pacing. AAIsafeR versions 1 or 2 significantly decreased the percentage of V pacing (9 \u00b1 21%) compared with DDD (95 \u00b1 14%), DDD\/AMC (31 \u00b1 34%), and DDI (87 \u00b1 20%) pacing (P<\/jats:italic> &lt; <jats:italic>0.00001). The mean percentage of V pacing was 12 \u00b1 24% (median 0%, range 0\u201394) in AAIsafeR1 versus 4 \u00b1 12% (median 0%, range 0\u201352) in AAIsafeR2 (P<\/jats:italic>=<jats:italic>0.055). In 16 devices upgraded from AAIsafeR version 1 to version 2, with follow\u2010up analyzable in both modes, the mean percentage of V pacing decreased from 6.4 \u00b1 15.1% to 2.6 \u00b1 9.7% (ns). No adverse effect related to the AAIsafeR modes was observed. No patient reported palpitation, dyspnea, or lightheadedness attributable to overdrive pacing by the AF prevention algorithms, and there was no rehospitalization, need for cardioversion, device\u2010related complication, or death.<\/jats:italic><\/jats:p><jats:p> <jats:italic>\n            <jats:bold>Conclusions:<\/jats:bold> In unselected pacemaker recipients, AAIsafeR reliably prevented V pacing compared with other pacing modes. No adverse effects were reported by any patient. Furthermore, maintaining spontaneous AV conduction protected the patients against ELT episodes.<\/jats:italic> <\/jats:p>","DOI":"10.1111\/j.1540-8159.2007.00608.x","type":"journal-article","created":{"date-parts":[[2007,1,18]],"date-time":"2007-01-18T22:34:01Z","timestamp":1169159641000},"source":"Crossref","is-referenced-by-count":8,"title":["AAIsafeR Limits Ventricular Pacing in Unselected Patients"],"prefix":"10.1111","volume":"30","author":[{"given":"GUY","family":"PIOGER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00c9RARD","family":"LENY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00c9MI","family":"NITZSCH\u00c9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALAIN","family":"RIPART","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,18]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa013040"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)03425-9"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.13.1315"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005113421902"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1460-9592.2001.00358.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199804163381602"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.97.10.987"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00757-5"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90244-X"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(01)01326-2"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000072769.17295.B1"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1986.tb06678.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1053\/eupc.1998.0026"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1988.tb06329.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.09.029"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.2005.00095.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euj024"},{"issue":"5","key":"e_1_2_7_19_2","first-page":"S169, P2","article-title":"Determining the optimal pacing mode to prevent ventricular pacing: SAVE R study results","volume":"3","author":"Davy JM","year":"2006","journal-title":"Heart Rhythm"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.2007.00608.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.2007.00608.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T06:59:26Z","timestamp":1695797966000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.2007.00608.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":18,"journal-issue":{"issue":"s1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1111\/j.1540-8159.2007.00608.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.2007.00608.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}